KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) FCF Margin (2016 - 2025)

Historic FCF Margin for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to 50.98%.

  • Gilead Sciences' FCF Margin fell 42600.0% to 50.98% in Q3 2025 from the same period last year, while for Sep 2025 it was 31.5%, marking a year-over-year decrease of 18300.0%. This contributed to the annual value of 35.84% for FY2024, which is 84700.0% up from last year.
  • Latest data reveals that Gilead Sciences reported FCF Margin of 50.98% as of Q3 2025, which was down 42600.0% from 10.17% recorded in Q2 2025.
  • Gilead Sciences' FCF Margin's 5-year high stood at 55.24% during Q3 2024, with a 5-year trough of 10.17% in Q2 2025.
  • Moreover, its 5-year median value for FCF Margin was 32.29% (2022), whereas its average is 32.42%.
  • Examining YoY changes over the last 5 years, Gilead Sciences' FCF Margin showed a top increase of 320800bps in 2024 and a maximum decrease of -161400bps in 2024.
  • Over the past 5 years, Gilead Sciences' FCF Margin (Quarter) stood at 42.09% in 2021, then fell by -23bps to 32.29% in 2022, then fell by -15bps to 27.47% in 2023, then skyrocketed by 36bps to 37.36% in 2024, then skyrocketed by 36bps to 50.98% in 2025.
  • Its FCF Margin stands at 50.98% for Q3 2025, versus 10.17% for Q2 2025 and 24.79% for Q1 2025.